Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ethan Brill
Apoptosis Is Augmented in High-Grade Serous Ovarian Cancer by the Combined Inhibition of BCL-2/BCL-xL and PARP
International Journal of Oncology
Cancer Research
Oncology
Related publications
Combined Inhibition of Notch Signaling and BCL-2/BCL-xL Results in Synergistic Antimyeloma Effect
Molecular Cancer Therapeutics
Cancer Research
Oncology
PARP Inhibitors in Platinum-Sensitive High-Grade Serous Ovarian Cancer
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Combined MEK and BCL-XL Inhibition Kills KRAS -Mutant Cells
Cancer Discovery
Oncology
Inhibition of Fas-Induced Apoptosis by BCL-2
Oncogene
Cancer Research
Genetics
Molecular Biology
High Glucose Inhibits Apoptosis Induced by Serum Deprivation in Vascular Smooth Muscle Cells via Upregulation of BCL-2 and BCL-Xl
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
The BCL-2 Proteins Noxa and BCL-xL Co-Ordinately Regulate Oxidative Stress-Induced Apoptosis
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology
ABT-737, a Small Molecule BCL-2/BCL-xL Antagonist, Increases Antimitotic-Mediated Apoptosis in Human Prostate Cancer Cells
PeerJ
Genetics
Molecular Biology
Biochemistry
Biological Sciences
Medicine
Agricultural
Neuroscience
High Expression of BCL-2 and BCL-Xl in Diffuse Large B-Cell Lymphoma Confer Poor Prognosis but May Be Reversible by Combined Inhibition With Bet Inhibitors and Bh3 Mimetics.
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Expression of Beclin-1, BCL-2, BCL-xL, Bad, and Bax in HCV Patients in Relation to Grade of Hepatic Fibrosis
Archives of Infectious Diseases & Therapy